Recruiting Esophageal Cancer Studies in Boston
A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
The purpose of this study to find out whether adding trastuzumab and pembrolizumab to standard chemotherapy is an effective treatment for resectable HER2+ esophagogastric cancer....
Folfox+Irinotecan+Chemort In Esophageal Cancer
In this research study, is studying how Liposomal Irinotecan in combination with the standard of care interventions FOLFOX, carboplatin paclitaxel, and radiation therapy affect gastroesophageal juncti...
About Esophageal Cancer Clinical Trials in Boston
Esophageal cancer occurs in the esophagus, the tube connecting the throat to the stomach. The two main types are squamous cell carcinoma and adenocarcinoma. Treatment may include surgery, chemotherapy, radiation, and immunotherapy.
There are currently 2 esophageal cancer clinical trials recruiting participants in Boston, MASSACHUSETTS. These studies are seeking a combined 89 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center, Massachusetts General Hospital. Clinical trial participation is free and participants receive study-related medical care at no cost.
Esophageal Cancer Clinical Trials in Boston — FAQ
Are there esophageal cancer clinical trials in Boston?
Yes, there are 2 esophageal cancer clinical trials currently recruiting in Boston, MASSACHUSETTS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Boston?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you about next steps.
Are clinical trials in Boston free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boston studies also compensate for your time and travel.
What esophageal cancer treatments are being tested?
The 2 active trials in Boston are testing new therapies including novel drugs, biologics, and treatment approaches for esophageal cancer.
Data updated March 2, 2026 from ClinicalTrials.gov